Mitochondrial quality control in liver fibrosis: Epigenetic hallmarks and therapeutic strategies

CONCLUSION: Mitochondrial quality control and epigenetic mechanisms are intricately linked to the pathogenesis of liver fibrosis. Understanding these molecular interactions provides insight into potential therapeutic strategies. Further research is necessary to translate these findings into clinical applications, with a focus on developing epigenetic drugs to ameliorate liver fibrosis by modulating MQC and epigenetic pathways.PMID:38182067 | DOI:10.1016/j.cellsig.2024.111035
Source: Cellular Signalling - Category: Cytology Authors: Source Type: research